NON SMALL CELL LUNG CARCINOMA
Clinical trials for NON SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Drug attack on deadly lung cancer being tested
Disease control Recruiting nowThis study is testing a new combination of two drugs for adults with advanced non-squamous lung cancer who haven't had prior treatment. The goal is to find the safest and most effective dose and see if the new combo works better than the current standard treatment. About 252 peop…
Matched conditions: NON SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Major trial tests new weapon against Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is for adults with advanced non-small cell lung cancer that has spread and has stopped responding to standard treatments. The goal is to see if a new drug, PF-08046054, works better and is safer than the current standard chemotherapy, docetaxel. About 680 participants …
Matched conditions: NON SMALL CELL LUNG CARCINOMA
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
First human trial launches for new cancer pill targeting specific genetic weakness
Disease control Recruiting nowThis is the first study in people testing a new oral drug called PLX-61639 for advanced solid tumors that have a specific genetic change (SMARCA4 mutation) and have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug shows early s…
Matched conditions: NON SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: Plexium, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Scientists test drug duo to reboot immune system against tough cancers
Disease control Recruiting nowThis early-stage trial is testing whether adding a pill called ruxolitinib to an immunotherapy drug (retifanlimab) is safe and can help control advanced lung or kidney cancer that has started growing again after prior immunotherapy. The study will enroll about 40 participants to …
Matched conditions: NON SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First-of-its-Kind pill targets Cancer's 'Guardian Gene' mutation
Disease control Recruiting nowThis study is testing a new oral drug, PC14586 (rezatapopt), for people with advanced solid tumors that have a specific mutation in a gene called TP53 (Y220C). The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. The trial is enrolling up…
Matched conditions: NON SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC